Hosted on MSN

Norovirus Is Surging Across The Country. Here Are The Symptoms To Look For, Per Infectious Disease Doctors

As if cold and flu season wasn't enough to deal with, there's another disease on the rise: norovirus. Norovirus cases have jumped up across the country, according to new data from the Centers for ...
Los Angeles Times

U.S. norovirus cases spiking this holiday season. Here’s how to avoid the stomach bug

With the winter cold and flu season upon us, Americans should be on the lookout for another ultra-contagious virus: our most common stomach bug. The U.S. experienced the largest December norovirus ...
Yahoo

Your stomach ache could be norovirus; what to look for and do

What you may think is a common stomach ache brought on by a strenuous holiday season may very well be a dangerous norovirus infection. And with norovirus infections spreading nationwide — along with ...
KXAN

Cocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and ...

There are currently no approved vaccines or treatments for norovirus infection Cocrystal’s CDI-988 is the first antiviral for the potential prevention and treatment of viral gastroenteritis caused by ...
WESH

Norovirus cases are surging. A doctor explains what to look for

A common stomach bug is surging, according to new data from the U.S. Centers for Disease Control and Prevention.In the week of Dec. 5, there were 91 outbreaks of norovirus reported, up from 69 the ...
Yahoo

If It Seems Like Everyone Has Norovirus, It's Because They Probably Do — Virus Is Surging, Says CDC

Stock image of toilet paper rolls in a bathroom. Cases of norovirus — the virulent, wildly contagious virus that causes vomiting and diarrhea — are increasing in the U.S., the Centers for Disease ...
Seeking Alpha

Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference

BOTHELL, Wash., July 10, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc (COCP). (Nasdaq: COCP) announces that its first-in-class pan-viral protease inhibitor CDI-988 has been selected for an oral ...